The Garvan-Weizmann partnership is an organisation- wide collaboration between two leading institutes with complementary research strengths.
The construction of the Garvan-Weizmann Centre for Cellular Genomics and solidifying of the partnership was enabled through a $5 million commitment from the NSW Government, matched by visionary donors. However, it is the research being produced through the Centre, and through the partnership, that will shape the future.
Before our partnership was formalised, there were already a number of research teams at the Garvan and Weizmann Institutes working together. Now, we are seeing the Garvan-Weizmann partnership strengthen and accelerate those collaborations.
The Garvan-Weizmann partnership has fostered inventive projects that seek to understand key aspects of melanoma, breast cancer, the spread of cancers to bone, cancer immunotherapy, immunology and diabetes – and ultimately to affect outcomes for individuals with these diseases. We invite you to explore five of the inaugural research projects here.
Importantly, the Centre’s facilities will be available to researchers beyond those at Garvan and Weizmann, kick-starting an era of rapid advances in the cell-by-cell understanding of how our tissues function in health and disease.
If you can, please consider investing in the innovative research of the Garvan Institute of Medical Research and the Weizmann Institute of Science.
Mr Andrew Giles
Chief Executive Officer, Garvan Research Foundation
Rina Michael and Andrew Giles
If you would like to discuss supporting the Garvan-Weizmann partnership, please call Mara-Jean on +61 (0) 2 9295 8513 or email email@example.com